Lidocaine, Menthol has 34 known drug interactions based on U.S. FDA drug labeling data. 33 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Acetaminophen, Acetazolamide, Articaine. Patients taking Lidocaine, Menthol should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 34
- Major
- 33
- Moderate
- 1
Major (33)
- Lidocaine, Menthol + Acetaminophen— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to acetaminophen.
- Lidocaine, Menthol + Acetazolamide— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antibiotics.
- Lidocaine, Menthol + Articaine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to local anesthetics.
- Lidocaine, Menthol + Benzocaine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to local anesthetics.
- Lidocaine, Menthol + Bupivacaine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to local anesthetics.
- Lidocaine, Menthol + Chloroquine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antimalarials.
- Lidocaine, Menthol + Cyclophosphamide— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antineoplastic agents.
- Lidocaine, Menthol + Dapsone— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antibiotics.
- Lidocaine, Menthol + Flutamide— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antineoplastic agents.
- Lidocaine, Menthol + Hydroxyurea— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antineoplastic agents.
- Lidocaine, Menthol + Ifosfamide— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antineoplastic agents.
- Lidocaine, Menthol + Mepivacaine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to local anesthetics.
- Lidocaine, Menthol + Metoclopramide— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to metoclopramide.
- Lidocaine, Menthol + Mexiletine— Concurrent use may result in additive and potentially synergistic toxic effects due to both being Class I antiarrhythmic…
- Lidocaine, Menthol + Nitric Oxide— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to oxidizing agents.
- Lidocaine, Menthol + Nitrofurantoin— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antibiotics.
- Lidocaine, Menthol + Nitroglycerin— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to nitrates.
- Lidocaine, Menthol + Nitroprusside— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to nitrites.
- Lidocaine, Menthol + Nitrous Oxide— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to oxidizing agents.
- Lidocaine, Menthol + Para-Aminosalicyclic Acid— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antibiotics.
- Lidocaine, Menthol + Para-Aminosalicylic Acid— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antibiotics.
- Lidocaine, Menthol + Phenobarbital— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to anticonvulsants.
- Lidocaine, Menthol + Phenytoin— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to anticonvulsants.
- Lidocaine, Menthol + Prilocaine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to local anesthetics.
- Lidocaine, Menthol + Primaquine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antimalarials.
- Lidocaine, Menthol + Procaine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to local anesthetics.
- Lidocaine, Menthol + Quinine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to quinine.
- Lidocaine, Menthol + Rasburicase— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antineoplastic agents.
- Lidocaine, Menthol + Ropivacaine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to local anesthetics.
- Lidocaine, Menthol + Sulfasalazine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to sulfa drugs.
- Lidocaine, Menthol + Tetracaine— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to local anesthetics.
- Lidocaine, Menthol + Tocainide— Concurrent use may result in additive and potentially synergistic toxic effects due to both being Class I antiarrhythmic…
- Lidocaine, Menthol + Valproate Sodium— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to anticonvulsants.
Moderate (1)
- Lidocaine, Menthol + Topical Local Anesthetics— When used concurrently with other local anesthetic products, total absorbed amount from all formulations must be conside…